Dose intensity in advanced ovarian cancer: Have we answered the question? Journal Article


Author: Fennelly, D.
Article Title: Dose intensity in advanced ovarian cancer: Have we answered the question?
Keywords: clinical trial; review; cisplatin; doxorubicin; paclitaxel; antineoplastic agent; ovarian neoplasms; carboplatin; ovary cancer; antineoplastic combined chemotherapy protocols; granulocyte macrophage colony stimulating factor; cyclophosphamide; dose-response relationship, drug; thiotepa; randomized controlled trials; mitoxantrone; epirubicin; drug dose; granulocyte colony stimulating factor; human; female; priority journal
Journal Title: Clinical Cancer Research
Volume: 1
Issue: 6
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 1995-06-01
Start Page: 575
End Page: 582
Language: English
PUBMED: 9816018
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 28 August 2018 -- Source: Scopus
Citation Impact
MSK Authors